RNA Outsourcing Resources
-
Biologics CDMO: 3 Qualities Often Overlooked
12/12/2025
A partnership can deliver more than process support. Transparency, regulatory expertise, and IP protection are critical benefits that safeguard your autonomy and innovation while enabling global success.
-
mRNA Manufacturing And Formulation
11/15/2022
From fermentation to formulation, mRNA manufacturing requires a toolbox of technologies, services, and expertise. Explore our portfolio of solutions for making, purifying, and formulating mRNA.
-
Eliminating Antibiotic Resistance Gene Transfer Risks In CGTs
8/14/2023
Learn about the drawbacks of antibiotic resistance that can cause side effects in patients and how an antibiotic-free approach can ease the burden of regulatory compliance and accelerate development.
-
Built Like A Tech Company: Why CROs Need A New Operating System
10/20/2025
See why building digital, automated infrastructure is essential, and better aligns CROs with today's speed, compliance, and innovation needs.
-
Screening T7 Polymerases To Optimize xRNA Yield And Quality
10/31/2025
Discover how the evolution of T7 polymerase is optimizing in vitro transcription for RNA therapeutics. Learn to balance performance, cost, and supply to make smart choices for your xRNA manufacturing.
-
Time: A Crucial Factor In Therapeutics Development
4/21/2025
Accelerate your mRNA development and strengthen your response to emerging health threats with next-generation, cell-free DNA template solutions designed for speed, quality, and reliability.
-
Identifying Sustainable Pathways Toward Oligonucleotide Therapeutics
What sustainable manufacturing processes best address Oligonucleotide environmental impact while maintaining scalability?
-
A New Centre For Continuous mRNA Manufacturing
5/14/2024
Explore how a partnership between academia, regulatory agencies, and manufacturing organizations has the potential to reshape the way we produce and distribute mRNA-based therapies.
-
Mastering mRNA Manufacturing: A Focus on Raw Materials & Supply Assurance
10/23/2024
Rapid advancements in mRNA-based therapeutic development have underscored the role of raw material quality and supply chain management in ensuring their successful production.
-
Phase-Appropriate Approaches To Manufacturing And Testing
3/14/2025
Accelerate the development of high-quality biopharmaceuticals by implementing phase-appropriate, risk-based manufacturing and testing strategies that ensure timely progression.